Following is the unofficial transcript of a CNBC interview with Novo Nordisk A/S (NYSE:NVO) CEO Lars Fruergaard Jørgensen, Novo Nordisk A/S Global Drug Discovery SVP Karin Conde-Knap
The US dollar's dominance is in decline as Russia and Saudi Arabia eye the Chinese yuan for oil trades, and investors might need to begin to revise their long-term investment strategies